Regeneron Pharmaceuticals, Inc. (REGN)
631.50
-3.12
(-0.49%)
USD |
NASDAQ |
May 27, 13:57
Regeneron Pharmaceuticals Free Cash Flow : 3.791B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.597B |
| AbbVie, Inc. | 19.98B |
| Biogen, Inc. | 2.316B |
| Eli Lilly & Co. | 10.37B |
| Merck & Co., Inc. | 14.12B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.079B |
| Cash from Investing (Quarterly) | -428.90M |
| Cash from Financing (Quarterly) | -802.20M |
| Free Cash Flow Per Share (Quarterly) | 7.422 |
| Free Cash Flow to Equity (Quarterly) | 1.066B |
| Free Cash Flow to Firm (Quarterly) | 810.69M |
| Free Cash Flow Yield | 5.57% |